Acurx Pharmaceuticals ACXP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.49 | 102.47 | -0.31 | -1,617 | -2 | |
| 2025Q3 | 4.29 | 101.81 | -1.00 | -2,029 | -2 | |
| 2025Q2 | 10.22 | 102.27 | -1.81 | -2,297 | -2 | |
| 2025Q1 | 7.80 | -2.20 | -2,149 | -2 | ||
| 2024Q4 | 16.28 | 99.71 | -3.22 | -2,774 | -3 | |
| 2024Q3 | 38.00 | 99.89 | -3.39 | -2,818 | -3 | |
| 2024Q2 | 45.00 | -5.24 | -4,122 | -4 | ||
| 2024Q1 | 49.00 | -5.60 | -4,378 | -4 | ||
| 2023Q4 | 76.60 | -7.60 | -5,115 | -5 | ||
| 2023Q3 | 30.00 | -4.80 | -3,115 | -3 | ||
| 2023Q2 | 53.00 | -5.60 | -3,445 | -3 | ||
| 2023Q1 | 69.20 | -5.00 | -2,903 | -3 | ||
| 2022Q4 | 79.60 | -5.60 | -3,261 | -3 | ||
| 2022Q3 | 60.00 | -6.40 | -3,542 | -4 | ||
| 2022Q2 | 75.80 | -5.20 | -2,621 | -3 | ||
| 2022Q1 | 65.60 | -5.20 | -2,670 | -3 | ||
| 2021Q4 | 86.43 | -4.40 | -2,627 | -3 | ||
| 2021Q3 | 102.80 | -9.60 | -4,642 | -5 | ||
| 2021Q2 | 127.60 | 101.67 | -11.60 | -4,071 | -4 | |
| 2021Q1 | -4.20 | -1,474 | -1 |